Germline Targeted Baboon Apolipoprotein L-1 Protects Mice Against African Trypanosomes
Sara FresardiD, Sarah J. PangburniD, Kayla Leiss, Daphne Boodwa-KoiD, Daniella KovacsicsiD, Christopher J. SchoenherriD, Jeremy S. RabinowitziD, Aris N. EconomidesiD, Li LiiD, Weigang QiuiD, B. González-BaradatiD, Alessandro RosaiD, Russell P. ThomsoniD, Jayne RaperiD, Joseph VerdiiD
Abstract
Certain primates are immune to infection by most African trypanosome parasites due to apolipoprotein L-1 (APOL1), a primate-specific ion channel-forming protein. To broaden our understanding of primate APOL1, we generated a panel of trypanosome-resistant murine models expressing various primate APOL1 proteins. We used these mice to investigate the role of APOL1 in trypanosome immunity in vivo by challenging them with various human and livestock trypanosome isolates. Baboon APOL1 provides partial protection to trypanosome isolates, though its protective capacity was limited by poor expression. A more highly expressed chimeric APOL1 encoding human APOL1 with the baboon APOL1 C-terminus was protective against human-infective trypanosomes, although with a fitness cost likely associated with high expression. We investigated the long-standing assumption that human resistance to Trypanosoma vivax is mediated by APOL1. Surprisingly, APOL1-expressing mice were fully susceptible to T. vivax infection, challenging this hypothesis. These model systems are useful tools for evaluating the possibility of generating genetic engineered livestock for disease control.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 4.63
- Field percentile
- top 8%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An invariant Trypanosoma vivax vaccine antigen inducing protective immunity
D. Autheman, C. Crosnier, … G. J. Wright·NaturePeer-reviewed·May 26, 2021
- Cure of experimental Trypanosoma vivax infection with a single dose of an unmodified antibody-based drug targeting the invariant flagellum cell surface protein IFX
Delphine Autheman, Cristina Viola, … Gavin James Wright·mBioPeer-reviewed·Oct 20, 2025
- In vitro trypanocidal effect of sera from Erythrocebus patas (Red patas monkey) and Chlorocebus tantalus (Tantalus monkey) on Trypanosoma brucei brucei Plimmer & Bradford, 1899 and Trypanosoma congolense Broden, 1894
F. Djieyep-Djemna, I. H. Nock, … A. C. N. Djieyep·bioRxiv·Jul 13, 2020
- Vivaxin genes encode highly immunogenic non-variant antigens unique to the Trypanosoma vivax cell-surface
A. Romero-Ramirez, A. Casas-Sanchez, … A. P. Jackson·bioRxiv·Feb 16, 2022
- Adipocyte lipolysis protects the host against Trypanosoma brucei infection
H. Machado, P. Hofer, … L. M. Figueiredo·bioRxiv·Nov 5, 2022
- No evidence for association with APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations
Magambo Phillip Kimuda, Harry A. Noyes, … Enock Matovu·PLoS neglected tropical diseasesPeer-reviewed·Feb 22, 2018